Clinical Trial Update: Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating dynamic ctDNA assessment in cervical and anal canal cancers to optimize follow-up and clinical outcomes. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: HPV-Related Carcinoma, Uterine Cervical Cancer | Phase 2 | Status: RECRUITING